505(b)(2) NDA Pipeline

About Genus Lifesciences

Genus Lifesciences is a commercial-stage, private pharmaceutical company with a focused strategy on the 505(b)(2) New Drug Application pathway. This approach allows it to efficiently bring previously unapproved, yet marketed, drugs into full regulatory compliance, addressing a specific market need and mitigating public health risks. The company maintains a diversified portfolio spanning human generics, authorized generics, and veterinary products, supported by in-house manufacturing capabilities. Its business model leverages regulatory expertise to build a sustainable pipeline of approved products.

Therapeutic Areas